| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |